Goolsbee at Antisense 40 mos. ago | SRPT Message Board Posts


Sarepta Therapeutics Inc.

  SRPT website

SRPT   /  Message Board  /  Read Message

 

 






Keyword
Subject
Between
and
Rec'd By
Authored By
Minimum Recs
  
Previous Message  Next Message    Post Message    Post a Reply return to message boardtop of board
Msg  14397 of 14405  at  10/19/2021 1:33:23 PM  by

schmiggins


 In response to msg 14396 by  schmiggins
view thread

Re: Goolsbee at Antisense 40 mos. ago


Good thorough analysis of the company from less than a year ago.

https://login.wilsonsadvisory.com.au/rsearch/Equity Research Report - ANP - 16 December 2020.pdf

A Sarepta paragraph:

"Ex-Sarepta expertise on hand.

Antisense have valuable experience from Sarepta Therapeutics, having two team members previously employed there, including being engaged in key activities related to launch of Exondys into the US market. William Goolsbee and Gil Price both bring differing experience and expertise from their Sarepta history. Dr Price having well established connections and networks into the US DMD investor base, key opinion leaders (KOLs) and patient advocacy groups (that wield significantly more power in the regulatory/drug development in DMD than might be expected) is an asset in longer term US market plays with ATL1102."

Me: Price just replaced Goolsbee on the Board a few days ago.


     e-mail to a friend      printer-friendly     add to library      
|  
Recs: 0  
   Views: 0 []
Previous Message  Next Message    Post Message    Post a Reply return to message boardtop of board


Financial Market Data provided by
.
Loading...